Search results
Results from the WOW.Com Content Network
Patiromer was generally well tolerated in studies. Side effects that occurred in more than 2% of patients included in clinical trials were mainly gastro-intestinal problems such as constipation, diarrhea, nausea, and flatulence, and also hypomagnesemia (low levels of magnesium in the blood) in 5% of patients, because patiromer binds magnesium in the gut as well.
Other approved potassium binders in the United States include patiromer and sodium polystyrene sulfonate. [14] Hyperkalemia, particularly if severe, is a marker for an increased risk of death. [15] However, there is disagreement regarding whether a modestly elevated levels directly causes problems.
Newer drugs include: another polyanionic polymer, patiromer, which exchanges calcium for potassium; and Sodium zirconium cyclosilicate crystals, which exchange sodium for potassium Increased serum potassium levels are a condition likely to occur in patients with chronic kidney disease in advanced stages.
Polystyrene sulfonates are a group of medications used to treat high blood potassium. [1] Effects generally take hours to days. [1] They are also used to remove potassium, calcium, and sodium from solutions in technical applications.
Main page; Contents; Current events; Random article; About Wikipedia; Contact us; Donate
ATC code V03 All other therapeutic products is a therapeutic subgroup of the Anatomical Therapeutic Chemical Classification System, a system of alphanumeric codes developed by the World Health Organization (WHO) for the classification of drugs and other medical products.
CSL Vifor is present in North and South America, Europe, the Middle East and Asia Pacific and is active in over 100 countries all around the world. [23] R&D sites of the group are located in Switzerland. [24]
Colestilan (INN, trade name BindRen) is a medication that acts as a phosphate binder [1] and bile acid sequestrant. [2] It is an ion-exchange resin, is an orally administered bile acid sequestrant that is being developed by Mitsubishi Tanabe Pharma Corporation for the treatment of hypercholesterolaemia and hyperphosphataemia.